Drug and pharmaceutical recalls

K.C. Pharmaceuticals issued a recall of Rugby Lubricating Eye Drops and Walgreens Lubricant Eye Drops because the manufacturer cannot guarantee the products are sterile. Non-sterile eye drops can introduce bacteria or other microorganisms into the eye. The recall affects specific lots (SY24K01 and SY24K02) with expiration dates of 09/30/26.

K.C. Pharmaceuticals has recalled multiple brands of sterile redness relief eye drops because they may not meet sterility standards. The affected products were distributed nationwide under various store and pharmacy brand names. No injuries have been reported so far.

K.C. Pharmaceuticals issued a recall of sterile eye drops sold under multiple brand names (including Walgreens, Good Sense, Kroger, CVS, and others) because the manufacturer cannot confirm the products remain sterile. The affected bottles were distributed nationwide. No injuries have been reported.

K.C. Pharmaceuticals is recalling multiple brands of ultra lubricating eye drops sold nationwide because the manufacturer cannot guarantee the drops are sterile. The affected products were distributed under names including Leader, Harris Teeter, Foster & Thrive, Walgreens, CVS Health, Kroger, Publix, Meijer, Good Sense, Quality Choice, and Avenova. No injuries have been reported.

K.C. Pharmaceuticals is recalling Dry Eye Relief Eye Drops sold under multiple store brands including Geri Care, TopCare, Rite Aid, Leader, and others due to concerns that the product may not be sterile. The recall affects 15 mL bottles with specific lot numbers and expiration dates sold nationwide.

K.C. Pharmaceuticals' Advanced Relief eye drops in 0.5 fl oz bottles may not be sterile due to a manufacturing issue. The affected products were sold under multiple store brands at Walgreens, Kroger, CVS, and other retailers nationwide. No infections have been reported so far.

K.C. Pharmaceuticals has recalled multiple brands of sterile eye drops (including Best Choice, Quality Choice, Discount Drug Mart, Good Sense, Walgreens, CareOne, Equaline, TopCare, Meijer, and H.E.B.) because the manufacturer cannot guarantee the products are sterile. Non-sterile eye drops can introduce infection into the eye. The affected products were distributed nationwide and have lot number AC24E01 with expiration date 05/31/26.

Amneal Pharmaceuticals is recalling specific lots of tramadol 50 mg tablets because they contain higher-than-allowed levels of a chemical impurity called N-nitroso-desmethyl-tramadol (NDSRI). The impurity was discovered during stability testing of tablets nearing the end of their shelf life. No injuries have been reported.

Alembic Pharmaceuticals is recalling specific lots of Bromfenac Ophthalmic Solution 0.07% because the medication failed purity and degradation tests during stability testing at 20 months. The affected eye drops may contain higher-than-acceptable impurity levels, which could affect safety and effectiveness.

Nalpac is recalling DTF Sexual Chocolate because it contains sildenafil and tadalafil—prescription drug ingredients found in Viagra and Cialis—that were not listed on the label. These hidden ingredients can dangerously lower blood pressure, especially if you take nitrate medications like nitroglycerin.

American Health Packaging is recalling specific batches of Meclizine Hydrochloride 12.5 mg tablets because they failed to meet required tablet specifications. The affected product is Lot #1024852 with an expiration date of 9/30/2026. No injuries have been reported.

Teva Pharmaceuticals is recalling specific lots of Octreotide Acetate 30 mg injectable suspension due to quality control problems found at the manufacturer. The FDA identified deficiencies that mean the sterility of these vials cannot be guaranteed. No injuries have been reported.

Teva Pharmaceuticals is recalling specific lots of Octreotide Acetate injectable suspension (20 mg) due to quality control issues at the manufacturing facility in Greece. The FDA found deficiencies that could affect sterility—the assurance that the medication is free from harmful bacteria and other microorganisms.

Teva Pharmaceuticals is recalling specific lots of Octreotide Acetate injectable suspension due to sterility concerns identified at the manufacturing facility. The FDA found quality system deficiencies that could affect the safety of the medication.

Macleods Pharma USA is recalling Levothyroxine Sodium Tablets USP 150 mcg because they may contain less active ingredient than labeled. This means the medication may not work as intended to treat thyroid conditions. The affected lot is 16240062A with an expiration date of March 2026.

Chiesi USA is recalling specific lots of CUROSURF, a medication given to premature infants to help them breathe. The company cannot confirm that all vials are sterile, which means they may be contaminated. No infections have been reported so far.

Radnostix Gelatin Capsule Packs used with Sodium Iodide I-131 Kit have failed quality specifications. The affected capsules may not perform as intended. Three specific lots distributed nationwide are involved.

Kian Pee Wan capsules, sold online as a dietary supplement for weight gain and appetite, contain two hidden prescription drugs: dexamethasone (a corticosteroid) and cyproheptadine (an antihistamine). These drugs were not listed on the label. Taking these undeclared drugs can cause serious health problems including infections, high blood sugar, psychiatric issues, and withdrawal symptoms if stopped abruptly.

Apotex Corp. is recalling specific lots of brimonidine tartrate/timolol maleate eye drops because the manufacturer cannot confirm the product was sterilized properly. The affected lots are VJ8599 (expires 09/30/2026) and VL1668 (expires 01/31/2027). No infections or injuries have been reported so far.

Somerset Therapeutics is recalling one lot of dexamethasone sodium phosphate injection because testing found impurity levels above acceptable limits as the product approached its expiration date. The affected lot (A240421, expiring 07/31/2026) was distributed nationwide. No injuries have been reported.

A 1 mg Pitavastatin tablet was found mixed into a bottle labeled as containing 2 mg tablets. This occurred in one lot (A252487) distributed in Tennessee. Taking the wrong dose by mistake could affect how well your cholesterol medication works.

Strides Pharma Children's Ibuprofen Oral Suspension (100 mg per 5 mL) has been recalled because some bottles contain gel-like masses and black particles. The affected bottles are 4 FL OZ (120 mL) size with lot numbers 7261973A or 7261974A, expiring 01/31/2027. No injuries have been reported.

One lot of Amneal Magnesium Sulfate in Water for Injection IV bags was found to contain the wrong medication—Tranexamic Acid—inside the packaging. This mix-up affects hospitals that received the product between late December 2025 and late February 2026. No patients have been harmed so far.

Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Mylan Pharmaceuticals is recalling specific lots of Amnesteem (isotretinoin) 40 mg capsules because they failed to meet dissolution specifications—meaning the medication may not break down and be absorbed by your body as intended. This could affect how well the medicine works. The recall affects two lots (3116110 and 3116130) with an expiration date of July 2026.

MR. 7 SUPER 700000 capsules contain hidden prescription drugs—sildenafil and tadalafil—that are not listed on the label. These are serious medications that can interact with other drugs and cause health problems. The product was sold without FDA approval.

Mojo Max Fusion XXX capsules contain hidden prescription drugs—sildenafil and tadalafil—that were not listed on the label. These are potent medications that can cause serious health problems, especially if you take other drugs or have certain heart or blood pressure conditions. The FDA has not approved this product for sale.

New Life Pharma LLC is recalling one lot of Tirzepatide 15mg injection due to lack of assurance of sterility. The affected lot (240709) was distributed in Ohio. No injuries have been reported.

New Life Pharma LLC is recalling Tirzepatide 10mg multi-dose vials (Lot 240709, expiration 7/31/2026) because the manufacturer cannot confirm the product is sterile. The vials were distributed in Ohio. No injuries have been reported.

New Life Pharma is recalling Nomida semaglutide 2 mg injection vials because the sterility of the product cannot be assured. The affected vials may not be safe to use. This recall affects a limited quantity distributed in Ohio.